aol.comSEP 273 min read

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

Original reporting

aol.com

Published Sep 27, 2026, 3:37 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 27, 2026, 4:23 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued? — source image — Source · aol.com

Decision brief

The 30-second read

Med

Why it matters

The earnings beat expectations on profitability but margin pressure and modest revenue growth temper enthusiasm.

Market read

First report of Q2 earnings for GTBIF, providing fresh data for traders evaluating cannabis stocks.

What to watch

Potential impact of upcoming Virginia recreational market launch in 2027.

Relevance 7/10Novelty 7/10Timing: after-hours earnings release

Background

Green Thumb Industries reports Q2 financials showing profit and cash flow, rare in the cannabis industry.

Market effects

Sector

Highlights profitability potential in U.S. cannabis sector, may influence peer valuations.

Regional

U.S. OTC cannabis stocks could see modest interest.

Global

Limited to investors focused on cannabis niche.

Counterpoint

What could challenge this read

Despite profitability, regulatory risk and price compression could keep the stock undervalued.

Key entities

Company
Green Thumb Industries
U.S. cannabis retailer reporting Q2 results.

Read at source ← All news

SEP 2

LowAI 8/10

Green Thumb Industries Inc. (CN: GTII) Stock Analysis: Is GTII a Sector Standout?

Green Thumb Industries (GTII) reported Q2 2026 revenue of $306.7M, up 4.6% YoY, with a gross margin of 45.0% (down from 49.9%). The company posted net income of $4.9M, adjusted earnings of $84.3M, and operating cash flow of $29.0M. GTII maintains a strong cash position of $283.6M, distinguishing itself in the cannabis sector.

kalkine.ca3 min

AUG 23

$CURLFHighAI 9/10

The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.

Curaleaf (CURLF) has proposed a $260M takeover of Aurora Cannabis (ACB), offering 0.3463 shares and $0.75 cash per share. Aurora, despite financial struggles, is attractive for its European market share. Green Thumb Industries (GTBIF), a profitable U.S. cannabis retailer, may also pursue acquisitions post-rescheduling, focusing on smaller, strategic deals.

yahoo.com2 min

AUG 11

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

tradingview.com2 min

AUG 4

$GTBIFMed

Green Thumb Industries Inc. (GTBIF): Results of Operations and Financial Condition

Green Thumb Industries Inc. (GTBIF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Green Thumb Industries Reports Second Quarter 2026 Results CHICAGO and VANCOUVER, British Columbia, August 4, 2026 (GLOBE NEWSWIRE) – Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer package

SEC EDGAR 8-K6 min

SEP 27

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.

insidermonkey.com2 min